Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Asset Writedowns and Impairment (2017 - 2020)

Historic Asset Writedowns and Impairment for Avricore Health (AVCRF) over the last 6 years, with Q4 2020 value amounting to $137721.6.

  • Avricore Health's Asset Writedowns and Impairment fell 1069.0% to $137721.6 in Q4 2020 from the same period last year, while for Dec 2020 it was $289793.5, marking a year-over-year increase of 5031.24%. This contributed to the annual value of -$563995.5 for FY2024, which is N/A changed from last year.
  • Avricore Health's Asset Writedowns and Impairment amounted to $137721.6 in Q4 2020, which was down 1069.0% from $321.93 recorded in Q3 2020.
  • In the past 5 years, Avricore Health's Asset Writedowns and Impairment ranged from a high of $256993.0 in Q1 2017 and a low of -$234773.0 during Q4 2017
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was -$1067.1 (2019), whereas its average is $20072.8.
  • The largest annual percentage gain for Avricore Health's Asset Writedowns and Impairment in the last 5 years was 15133.5% (2018), contrasted with its biggest fall of 25259.34% (2018).
  • Quarter analysis of 4 years shows Avricore Health's Asset Writedowns and Impairment stood at -$234773.0 in 2017, then skyrocketed by 151.33% to $120520.6 in 2018, then increased by 27.95% to $154206.2 in 2019, then dropped by 10.69% to $137721.6 in 2020.
  • Its Asset Writedowns and Impairment stands at $137721.6 for Q4 2020, versus $321.93 for Q3 2020 and $154206.2 for Q4 2019.